<b> <i>Retracted:</i> </b> MiR-181a Promotes Apoptosis and Reduces Cisplatin Resistance by Inhibiting Osteopontin in Cervical Cancer Cells

Xiaofei Xu, Xiaofei Jiang, Liping Chen, Yu Zhao, Zhihua Huang, Huifang Zhou, Mingqing Shi

Cancer Biotherapy and Radiopharmaceuticals · 2019 · 19 citations · 26 references

Concepts

Abstract

Cancer Biotherapy and Radiopharmaceuticals officially retracts the paper entitled, “MiR-181a Promotes Apoptosis and Reduces Cisplatin Resistance by Inhibiting Osteopontin in Cervical Cancer Cells,” by Xiaofei Xu, Xiaofei Jiang, Liping Chen, Yu Zhao, Zhihua Huang, Huifang Zhou, and Mingqing Shi (Cancer Biother Radiopharm. 2019;34(9)559–565; doi: 10.1089/cbr.2019.2858) due to the discovery that the paper was submitted from a paper mill. This is a violation of the journal's standard protocols and is considered an infraction against the rigorous standards of scientific publishing. The Editor and Publisher of Cancer Biotherapy and Radiopharmaceuticals are committed to preserving the scientific literature and the community it serves, and does not tolerate any improprieties.

References

26